GL Pharm Tech Corp. (KOSDAQ:204840)
South Korea · Delayed Price · Currency is KRW 1,100.00
-30.00 (-2.65%)
At close: Feb 13, 2026
GL Pharm Tech Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 307.33 | -2,337 | -3,749 | -790.17 | -3,727 | -3,356 |
Depreciation & Amortization | 1,133 | 1,710 | 2,138 | 2,145 | 2,040 | 1,949 |
Loss (Gain) From Sale of Assets | -1.08 | -17.5 | -0.44 | -1,714 | 24.82 | -82.38 |
Asset Writedown & Restructuring Costs | - | - | - | - | 278.13 | - |
Loss (Gain) From Sale of Investments | -0.02 | - | -12.02 | -6.85 | - | - |
Loss (Gain) on Equity Investments | -9.46 | -20.13 | 13.13 | - | - | - |
Stock-Based Compensation | 9.54 | - | - | - | 114.28 | 201.72 |
Provision & Write-off of Bad Debts | 66.18 | -174.41 | 35.19 | -15.99 | 26.76 | -28.4 |
Other Operating Activities | 1.07 | 226.9 | -147.96 | -742.45 | 470.67 | 838.98 |
Change in Accounts Receivable | -3,784 | -11.43 | -139.29 | -2,019 | 15.88 | -164.69 |
Change in Inventory | -3,124 | -1,949 | -988.09 | -2,192 | -579.06 | -711.24 |
Change in Accounts Payable | 1,191 | -593.43 | -540.35 | 2,481 | -271.64 | -134.6 |
Change in Other Net Operating Assets | 612.56 | -1,481 | -369.33 | 1,585 | -663.83 | -1,136 |
Operating Cash Flow | -3,598 | -4,648 | -3,760 | -1,269 | -2,271 | -2,666 |
Capital Expenditures | -2,621 | -391.81 | -579.32 | -6,438 | -1,328 | -1,098 |
Sale of Property, Plant & Equipment | 0 | 18.18 | 0.44 | 2,095 | 2.95 | 244.87 |
Sale (Purchase) of Intangibles | - | - | - | -7.02 | -7.96 | - |
Investment in Securities | - | - | 26.92 | -1,000 | -506.25 | 547.21 |
Other Investing Activities | -1,341 | -1,349 | -12.59 | -12.61 | -45.61 | 0.64 |
Investing Cash Flow | -3,514 | -1,580 | -570.14 | -5,435 | -1,897 | 808.52 |
Short-Term Debt Issued | - | 1,000 | 3,900 | 1,550 | 500 | 1,454 |
Long-Term Debt Issued | - | - | 5,810 | 10,400 | - | 11,800 |
Total Debt Issued | 9,531 | 1,000 | 9,710 | 11,950 | 500 | 13,254 |
Short-Term Debt Repaid | - | -1,917 | -1,550 | -1,500 | -513.3 | -2,753 |
Long-Term Debt Repaid | - | -2,013 | -4,409 | -4,453 | -453.73 | -12,930 |
Total Debt Repaid | -6,974 | -3,930 | -5,959 | -5,953 | -967.03 | -15,682 |
Net Debt Issued (Repaid) | 2,556 | -2,930 | 3,751 | 5,997 | -467.03 | -2,428 |
Issuance of Common Stock | 148 | 9,280 | 75 | 75 | 412.88 | 13,451 |
Other Financing Activities | 0 | 0 | 0 | -0.98 | 921.82 | -0 |
Financing Cash Flow | 2,704 | 6,350 | 3,826 | 6,071 | 867.67 | 11,023 |
Foreign Exchange Rate Adjustments | - | - | - | -19.66 | - | - |
Miscellaneous Cash Flow Adjustments | 0 | 0 | - | -896.68 | 0 | 0 |
Net Cash Flow | -4,407 | 121.95 | -503.67 | -1,549 | -3,301 | 9,166 |
Free Cash Flow | -6,219 | -5,039 | -4,339 | -7,707 | -3,600 | -3,765 |
Free Cash Flow Margin | -18.13% | -19.35% | -16.67% | -46.07% | -28.97% | -31.40% |
Free Cash Flow Per Share | -80.99 | -67.86 | -69.72 | -124.25 | -70.78 | -83.67 |
Cash Interest Paid | 574.38 | 777.13 | 788.02 | 382.07 | 349.6 | 409.22 |
Cash Income Tax Paid | - | 19.24 | -19.23 | 8.17 | 22.53 | -6.16 |
Levered Free Cash Flow | -6,145 | -3,260 | -2,672 | -6,965 | -2,882 | -2,698 |
Unlevered Free Cash Flow | -5,780 | -2,779 | -2,183 | -6,699 | -2,340 | -2,181 |
Change in Working Capital | -5,104 | -4,035 | -2,037 | -144.54 | -1,499 | -2,188 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.